M Falcone1, G Tiseo2, C Tascini3, A Russo4, E Sozio3, G Raponi4, C Rosin5, P Pignatelli2, P Carfagna6, A Farcomeni4, R Luzzati5, F Violi2, F Menichetti3, M Venditti4. 1. Department of Public Health and Infectious Diseases, "Sapienza" University of Rome, Italy. Electronic address: marco.falcone@uniroma1.it. 2. Department of Internal Medicine and Medical Specialties, "Sapienza" University of Rome, Italy. 3. Infectious Diseases Unit, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy. 4. Department of Public Health and Infectious Diseases, "Sapienza" University of Rome, Italy. 5. University Hospital of Trieste, Trieste, Italy. 6. San Giovanni Addolorata Hospital, Rome, Italy.
Abstract
BACKGROUND: An increasing prevalence of candidemia has been reported in Internal Medicine wards (IMWs). The aim of our study was to identify risk factors for candidemia among non-neutropenic patients hospitalized in IMWs. METHODS: A multicenter case-control study was performed in three hospitals in Italy. Patients developing candidemia (cases) were compared to patients without candidemia (controls) matched by age, time of admission and duration of hospitalization. A logistic regression analysis identified risk factors for candidemia, and a new risk score was developed. Validation was performed on an external cohort of patients. RESULTS: Overall, 951 patients (317 cases of candidemia and 634 controls) were included in the derivation cohort, while 270 patients (90 patients with candidemia and 180 controls) constituted the validation cohort. Severe sepsis or septic shock, recent Clostridium difficile infection, diabetes mellitus, total parenteral nutrition, chronic obstructive pulmonary disease, concomitant intravenous glycopeptide therapy, presence of peripherally inserted central catheter, previous antibiotic therapy and immunosuppressive therapy were factors independently associated with candidemia. The new risk score showed good area under the curve (AUC) values in both derivation (AUC 0.973 95% CI 0.809-0.997, p<0.001) and validation cohort (0.867 95% CI 0.710-0.931, p<0.001). A threshold of 3 leads to a sensitivity of 87% and a specificity of 83%. CONCLUSION: Non-neutropenic patients admitted in IMWs have peculiar risk factors for candidemia. A new risk score with a good performance could facilitate the identification of candidates to early antifungal therapy.
BACKGROUND: An increasing prevalence of candidemia has been reported in Internal Medicine wards (IMWs). The aim of our study was to identify risk factors for candidemia among non-neutropenicpatients hospitalized in IMWs. METHODS: A multicenter case-control study was performed in three hospitals in Italy. Patients developing candidemia (cases) were compared to patients without candidemia (controls) matched by age, time of admission and duration of hospitalization. A logistic regression analysis identified risk factors for candidemia, and a new risk score was developed. Validation was performed on an external cohort of patients. RESULTS: Overall, 951 patients (317 cases of candidemia and 634 controls) were included in the derivation cohort, while 270 patients (90 patients with candidemia and 180 controls) constituted the validation cohort. Severe sepsis or septic shock, recent Clostridium difficileinfection, diabetes mellitus, total parenteral nutrition, chronic obstructive pulmonary disease, concomitant intravenous glycopeptide therapy, presence of peripherally inserted central catheter, previous antibiotic therapy and immunosuppressive therapy were factors independently associated with candidemia. The new risk score showed good area under the curve (AUC) values in both derivation (AUC 0.973 95% CI 0.809-0.997, p<0.001) and validation cohort (0.867 95% CI 0.710-0.931, p<0.001). A threshold of 3 leads to a sensitivity of 87% and a specificity of 83%. CONCLUSION:Non-neutropenicpatients admitted in IMWs have peculiar risk factors for candidemia. A new risk score with a good performance could facilitate the identification of candidates to early antifungal therapy.
Authors: Andrea Ripoli; Emanuela Sozio; Francesco Sbrana; Giacomo Bertolino; Carlo Pallotto; Gianluigi Cardinali; Simone Meini; Filippo Pieralli; Anna Maria Azzini; Ercole Concia; Bruno Viaggi; Carlo Tascini Journal: Infection Date: 2020-08-01 Impact factor: 3.553
Authors: Francesco Sbrana; Emanuela Sozio; Matteo Bassetti; Andrea Ripoli; Filippo Pieralli; Anna Maria Azzini; Alessandro Morettini; Carlo Nozzoli; Maria Merelli; Sebastiano Rizzardo; Giacomo Bertolino; Davide Carrara; Claudio Scarparo; Ercole Concia; Francesco Menichetti; Carlo Tascini Journal: Intern Emerg Med Date: 2018-01-10 Impact factor: 3.397
Authors: Christophe d'Enfert; Ann-Kristin Kaune; Leovigildo-Rey Alaban; Sayoni Chakraborty; Nathaniel Cole; Margot Delavy; Daria Kosmala; Benoît Marsaux; Ricardo Fróis-Martins; Moran Morelli; Diletta Rosati; Marisa Valentine; Zixuan Xie; Yoan Emritloll; Peter A Warn; Frédéric Bequet; Marie-Elisabeth Bougnoux; Stephanie Bornes; Mark S Gresnigt; Bernhard Hube; Ilse D Jacobsen; Mélanie Legrand; Salomé Leibundgut-Landmann; Chaysavanh Manichanh; Carol A Munro; Mihai G Netea; Karla Queiroz; Karine Roget; Vincent Thomas; Claudia Thoral; Pieter Van den Abbeele; Alan W Walker; Alistair J P Brown Journal: FEMS Microbiol Rev Date: 2021-05-05 Impact factor: 16.408
Authors: Marco Falcone; Giusy Tiseo; Belen Gutiérrez-Gutiérrez; Giammarco Raponi; Paolo Carfagna; Chiara Rosin; Roberto Luzzati; Diego Delle Rose; Massimo Andreoni; Alessio Farcomeni; Mario Venditti; Jesus Rodríguez-Baño; Francesco Menichetti Journal: Open Forum Infect Dis Date: 2019-07-16 Impact factor: 3.835
Authors: Priscila Guerino Vilela Alves; Sávia Gonçalves Oliveira Melo; Meliza Arantes de Souza Bessa; Murilo de Oliveira Brito; Ralciane de Paula Menezes; Lúcio Borges de Araújo; Mário Paulo Amante Penatti; Reginaldo Dos Santos Pedroso; Denise Von Dolinger de Brito Röder Journal: Rev Soc Bras Med Trop Date: 2020-06-22 Impact factor: 1.581
Authors: Adriana M Rauseo; Abdullah Aljorayid; Margaret A Olsen; Lindsey Larson; Kim L Lipsey; William G Powderly; Andrej Spec Journal: Med Mycol Date: 2021-11-03 Impact factor: 3.747
Authors: Christian Ortega-Loubon; Beatriz Cano-Hernández; Rodrigo Poves-Alvarez; María Fe Muñoz-Moreno; Patricia Román-García; Sara Balbás-Alvarez; Olga de la Varga-Martínez; Esther Gómez-Sánchez; Estefanía Gómez-Pesquera; Mario Lorenzo-López; Eduardo Tamayo; María Heredia-Rodríguez Journal: J Clin Med Date: 2019-09-20 Impact factor: 4.241